Baxter Theranova: More Middle Molecules, Less Albumin Loss

Baxter’s new dialyzer mimics the function of natural kidneys more closely, removing more middle molecules with no replacement fluid needed—and minimal loss of vital albumin. The new expanded hemodialysis (HDx) therapy has been tested in the UK, where it reduced beta-2 microglobulin levels by more than 11%

Read the full article » | Posted 12-14-2017

Related Articles

• The Top 10 Catheter Innovations of 2020 Posted 01-12-2021
• Researchers Use Technology To Print Miniature Human Kidneys In Lab Posted 12-10-2020
• New Drug for Dialysis-related Itching Posted 11-12-2020
• Diality Raises $12.5M for its Portable Home HD System Posted 11-12-2020